UBS O'Connor’s Carter's CRI Stock Holding History

UBS O'Connor’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-50,000	Closed	-$4.34M	–	413
2016 Q3	$4.34M	Buy	+50,000	New	+$5.02M	0.06%	225
2015 Q4	–	Sell	-100,000	Closed	-$9.06M	–	438
2015 Q3	$9.06M	Buy	+100,000	New	+$10M	0.18%	135

Other funds holding CRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS O'Connor's CRI Position: Q4 2016 in Review

UBS O'Connor sold out of Carter's (CRI) in Q4 2016, closing a stake of 50,000 shares — an estimated $4.34M sold.

UBS O'Connor first reported a position in CRI in Q3 2015 and held it in 2 quarters. The position peaked at $9.06M in Q3 2015. 329 funds tracked by Wall St. Rank hold CRI as of Q4 2016.

UBS O'Connor reported no remaining Carter's position as of Q4 2016 after selling out during the quarter.
UBS O'Connor sold 50,000 Carter's shares in Q4 2016, an estimated $4.34M.
UBS O'Connor first reported a position in Carter's in Q3 2015 and held it in 2 quarters.
UBS O'Connor's Carter's position peaked at $9.06M in Q3 2015.
329 funds tracked by Wall St. Rank held Carter's as of Q4 2016.

Based on UBS O'Connor's 13F filing for Q4 2016, filed 14 Feb 2017.